| 英文别名 |
Tandutinib;CT53518;MLN518;1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-;4-(6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide;Unii-E1io3icj9a;Tandutinib(CT 53518);Tandutinib (MLN518);4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-Methylethoxy)phenyl]-;N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide;CT-53518;MLN-518;Tandutinib for research;4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl);(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide;MLN 518;CT 53518;E1IO3ICJ9A;NSC726292;DSSTox_RID_83142;DSSTox_CID_28873;DSSTox_GSID_48947;4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quin;Tandutinib (USAN/INN);4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide;NSC800942;NSC-759851;DTXSID8048947;NSC 759851;4-[6-Methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide;Pharmakon1600-01502277;AMY32698;AC-1659;Tandutinib [USAN];NS00069682;Tox21_113366;1227636-17-0;TANDUTINIB (CT53518);TANDUTINIB [WHO-DD];DTXCID5028873;MLN-0518;HMS3654O09;NSC759851;HMS3244A22;Tox21_113366_1;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide;HMS3244B21;BCP01370;NSC-760841;cid_3038522;EX-A1637;SMR004702776;HMS3745A09;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-(3-piperidinopropoxy)quinazolin-4-yl]piperazine-1-carboxamide;NCGC00241097-07;NSC-726292;Tandutinib [USAN:INN];BDBM13535;HMS3244A21;Tandutinib(MLN518);BCPP000051;D06005;MLS006010972;NCGC00241097-03;CHEMBL124660;4-[7-(3-Piperidin-1-yl-propoxy)-quinazolin-4-yl]-piperazine-1-carboxylic acid (4-isopropoxy-phenyl)-amide;FT-0653217;SCHEMBL927974;387867-13-2;SW218125-2;NSC-800942;A824282;MLN518, Tandutinib;SB19380;ES-0051;s1043;NCGC00241097-02;CS-0128;AKOS015902621;4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide;4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide;Tandutinib pound MLN518, CT53518 pound(c);Kinome_3320;4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-(4-propan-2-yloxyphenyl)-1-piperazinecarboxamide;Q-201778;NSC760841;CCG-213017;4-(6-Methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(1-methylethoxy)phenyl)piperazine-1-carboxamide;CAS-387867-13-2;MFCD09954147;tandutinibum;BRD-K89162000-001-01-5;AB01562955_01;DB05465;Q27095683;CHEBI:90237;TANDUTINIB [INN];HY-10202;NCGC00241097-01;HMS3264G08;BRD-K89162000-001-07-2;SDCCGSBI-... |